<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02025361</url>
  </required_header>
  <id_info>
    <org_study_id>Cancer detection in TRUS-Bx</org_study_id>
    <nct_id>NCT02025361</nct_id>
  </id_info>
  <brief_title>Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy</brief_title>
  <official_title>Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bagcilar Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bagcilar Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transrectal ultrasound guided prostate biopsy (TRUS-Bx) is the gold standard method for
      prostat cancer diagnosis. Cancer detection rate is an important issue in TRUS-Bx. Effective
      biopsy protocol is necessary to enhance cancer detection rate during the procedure. Patient
      tolerance may improve the protocol effectiveness and quality.

      Adequate patient tolerance with optimal local anesthesia may enhance cancer detection rate in
      TRUS-Bx.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In transrectal ultrasound guided prostate biopsy ultrasound's probe manipulation is necessary
      for effective biopsy. Patient discomfort and pain frequently occurs with manipulation of
      probe during transrectal ultrasound guided prostate biopsy and this situation may qualify of
      the achievement of this procedure.

      In this study, we aimed to describe the impact of different two local anesthesia types on
      cancer detection rate in transrectal ultrasound guided prostate biopsy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cancer detection rate with anesthesia type</measure>
    <time_frame>finally pathologic evaluation within 2-3 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">422</enrollment>
  <condition>Adenocarcinoma of Prostate</condition>
  <arm_group>
    <arm_group_label>intrarectal lidocaine gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>transrectal ultrasound guided prostate biopsy was performed with intrarectal lidocaine gel anesthesia: 10 minutes before the procedure % 2 lidocaine hydrochloride gel instilated into the rectum for local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>periprostatic nerve blockade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>transrectal ultrasound guided prostate biopsy was performed with intrarectal lidocaine gel anesthesia: 10 minutes before the procedure transrectal ultrasound guided 10 ml prilocaine and serum physiologic blend (5ml %2 prilocaine and 5 ml serum physiologic) injected separetly 5ml right and 5ml left junction between the prostate base and seminal vesicle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intrarectal lidocaine gel</intervention_name>
    <description>intrarectal local anesthetic application</description>
    <arm_group_label>intrarectal lidocaine gel</arm_group_label>
    <other_name>No name</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>periprostatic nerve blockade</intervention_name>
    <description>periprostatic local anesthetic application</description>
    <arm_group_label>periprostatic nerve blockade</arm_group_label>
    <other_name>No name</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who underwent transrectal ultrasound guided prostate biopsy because of
             elevated serum PSA levels and/or suspicious rectal examination of prostate.

        Exclusion Criteria:

          -  Previous TRUS-Bx and prostatic operations(TUR-P, open prostatectomy, etc..) history,
             treatment for prostate carcinoma, usage of finasteride and dutasteride.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mustafa z temiz</last_name>
    <role>Principal Investigator</role>
    <affiliation>bagcilar training and research hospital-depertmant of urology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bagcilar Training and Research Hospital-Depertmant of urology</name>
      <address>
        <city>Istanbul</city>
        <state>Bagcilar</state>
        <zip>34100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2013</study_first_submitted>
  <study_first_submitted_qc>December 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2014</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bagcilar Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Mustafa Zafer Temiz</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>prostate biopsy, local anesthesia, cancer detection rate.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

